Adjuvant Nonavalent HPV Vaccination in Women Treated for Vulvar HSIL, a Randomised Placebo Controlled Trial
Latest Information Update: 29 Sep 2023
At a glance
- Drugs V 503 (Primary)
- Indications Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms VulVaccin
Most Recent Events
- 29 Sep 2023 New trial record